About Eltrombopag Olamine
Class: | Thrombopoietin receptor agonist
Use: | Treatment of thrombocytopenia in patients with chronic immune thrombocytopenic purpura (ITP), chronic hepatitis C, and severe aplastic anemia
Adult dose: | 25 mg once daily; may be adjusted based on platelet counts and clinical response
Pediatric dose: | For ITP in children ≥1 year: starting dose is 12.5 mg once daily; may be adjusted based on platelet counts
Side effects: | Nausea, vomiting, diarrhea, headache, fatigue, abdominal pain, and
Drug Class
Thrombopoietin receptor agonist
Uses & Indications
Treatment of thrombocytopenia in patients with chronic immune thrombocytopenic purpura (ITP), chronic hepatitis C, and severe aplastic anemia
Storage Requirements
Store at 20°C to 25°C (68°F to 77°F); protect from moisture and light
Manufacturer & Packaging
Manufacturer: Novartis Pharma AG, SWITZERLAND
Package Size
28's (7's Blister x 4)
Price & Supplier
Price in UAE: AED 5858.50
Dosage Information
Adult Dose
25 mg once daily; may be adjusted based on platelet counts and clinical response
Pediatric Dose
For ITP in children ≥1 year: starting dose is 12.5 mg once daily; may be adjusted based on platelet counts
Side Effects
Nausea, vomiting, diarrhea, headache, fatigue, abdominal pain, and increased liver enzymes
Contraindications & Precautions
Hypersensitivity to eltrombopag or any component of the formulation; severe liver impairment
Important Warnings
Risk of hepatotoxicity; monitor liver function tests; risk of thrombosis; not recommended in patients with active thromboembolic disease
Medical Disclaimer
This information is for educational purposes only and should not replace professional medical advice.
Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication.
The information presented here is specific to medicines available in UAE pharmacies and is regularly updated
to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.